Log in to save to my catalogue

Association between contrast enhancement on contrast‑enhanced CT and lenvatinib effectiveness in hep...

Association between contrast enhancement on contrast‑enhanced CT and lenvatinib effectiveness in hep...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8647186

Association between contrast enhancement on contrast‑enhanced CT and lenvatinib effectiveness in hepatocellular carcinoma

About this item

Full title

Association between contrast enhancement on contrast‑enhanced CT and lenvatinib effectiveness in hepatocellular carcinoma

Publisher

Athens: Spandidos Publications

Journal title

Molecular and clinical oncology, 2022-01, Vol.16 (1), Article 8

Language

English

Formats

Publication information

Publisher

Athens: Spandidos Publications

More information

Scope and Contents

Contents

The aim of the present study was to investigate whether the degree of contrast enhancement on contrast-enhanced (CE)-CT can predict the prognosis of patients with hepatocellular carcinoma (HCC) treated with lenvatinib (LEN). A total of 67 consecutive patients with LEN-treated HCC were retrospectively analysed. In the pretreatment CE-CT, the CT valu...

Alternative Titles

Full title

Association between contrast enhancement on contrast‑enhanced CT and lenvatinib effectiveness in hepatocellular carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8647186

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8647186

Other Identifiers

ISSN

2049-9450

E-ISSN

2049-9469

DOI

10.3892/mco.2021.2442

How to access this item